Disha Malani

Innovative oncology and data science leader with 12+ years of experience driving precision medicine strategy and translational data science in hematology and solid tumors. Proven success in integrating RWA & RWE, next-generation sequencing (NGS), clinical trial data, and AI/ML to accelerate data-driven treatment decision-making. Adept at building cross-functional collaborations across clinical, informatics, and regulatory teams. Deep domain expertise in hematologic malignancies, oncology drug development, diagnostics, and digital health platforms. Experienced in U.S. and global regulatory environments, with a strong foundation in clinical informatics and product strategy.

Core Competencies

• Hematology-Oncology Data Strategy & Scientific Leadership
• Precision Medicine & Clinical Biomarkers
• Real-World Evidence (RWE) & Digital Health Analytics
• AI/ML-Enabled Clinical Decision Support
• NGS Diagnostics & Translational Informatics
• Cross-Functional Team Leadership & Regulatory Readiness
• EHR Integration (Epic) & Clinical Trial Data Analysis
• External Partnerships & Scientific Engagement
• HIPAA, GDPR, IRB, CLIA Compliance

MIT Sloan School of Management – MBA, Strategy & AI in Biomedicine
Cambridge, MA | 2025 (Expected)

University of Helsinki – PhD, Precision Oncology
Helsinki, Finland | 2018

Nottingham Trent University – MRes, Molecular Biology
Nottingham, UK | 2010